China cholesterol education program (CCEP) expert advice for the management of dyslipidaemias to reduce cardiovascular risk (2019)
CCEPCW Committee… - Zhonghua nei ke za …, 2020 - pubmed.ncbi.nlm.nih.gov
The prevalence of dyslipidemia in Chinese adult is increasing dramatically, which poses a
severe challenge to the prevention and treatment of atherosclerotic cardiovascular diseases …
severe challenge to the prevention and treatment of atherosclerotic cardiovascular diseases …
Global prevalence of dyslipidaemia in adult populations: a systematic review protocol
Introduction Dyslipidaemia is one of the established risk factors for cardiovascular disease.
Evidence from large-scale trials showed that effective treatment of dyslipidaemia can reduce …
Evidence from large-scale trials showed that effective treatment of dyslipidaemia can reduce …
New guidelines and evidence for prevention and treatment of dyslipidemia and atherosclerotic cardiovascular disease in China☆
DY Hu - Chronic diseases and translational medicine, 2017 - mednexus.org
The “2016 Chinese guideline for the management of dyslipidemia in adults”(the new Guide
for short) released by Chinese Journal of Cardiology is based on the 2007 “Guide for …
for short) released by Chinese Journal of Cardiology is based on the 2007 “Guide for …
Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: a nationally representative survey of 163,641 adults
M Zhang, Q Deng, L Wang, Z Huang, M Zhou… - International journal of …, 2018 - Elsevier
Background Elevated serum total cholesterol and low-density lipoprotein cholesterol (LDL-
C) levels are established risk factors for cardiovascular diseases, a leading cause of death …
C) levels are established risk factors for cardiovascular diseases, a leading cause of death …
High prevalence of dyslipidemia and associated risk factors among rural Chinese adults
GZ Sun, Z Li, L Guo, Y Zhou, HM Yang… - Lipids in health and …, 2014 - Springer
Background Dyslipidemia is a key independent modifiable risk factor for Cardiovascular
Disease, which is a leading contributor to morbidity and mortality in most developed and …
Disease, which is a leading contributor to morbidity and mortality in most developed and …
Global trends in the epidemiology and management of dyslipidemia
T Liu, D Zhao, Y Qi - Journal of clinical medicine, 2022 - mdpi.com
Dyslipidemia, especially a circulating non-optimal level of cholesterol, is one of the most
important risk factors for atherosclerotic cardiovascular disease (ASCVD), which accounts …
important risk factors for atherosclerotic cardiovascular disease (ASCVD), which accounts …
Prevalence of dyslipidemia and its control in type 2 diabetes: a multicenter study in endocrinology clinics of China
L Yan, MT Xu, L Yuan, B Chen, ZR Xu, QH Guo… - Journal of clinical …, 2016 - Elsevier
Objective The aim of this study was to assess the levels of serum lipid and awareness,
treatment, and control of dyslipidemia in type 2 diabetes mellitus (T2DM) patients from top …
treatment, and control of dyslipidemia in type 2 diabetes mellitus (T2DM) patients from top …
Prevalence, awareness, treatment, and control of dyslipidemia among diabetes mellitus patients and predictors of optimal dyslipidemia control: results from the Korea …
Background This study aimed to investigate the prevalence, awareness, treatment, and
control rates of dyslipidemia and identify the predictors of optimal control (low-density …
control rates of dyslipidemia and identify the predictors of optimal control (low-density …
The status quo of Chinese prevention and treatment of dyslipidemia
D HU - Chinese Journal of Practical Internal Medicine, 2003 - pesquisa.bvsalud.org
Although the incidence of dyslipidemia in Chinese population is increasing, the awareness
rate, control rate and target rate of dyslipidemia are still low. Many doctors couldn't well …
rate, control rate and target rate of dyslipidemia are still low. Many doctors couldn't well …
Serum lipids and associated factors of dyslipidemia in the adult population in Shenzhen
WQ Ni, XL Liu, ZP Zhuo, XL Yuan, JP Song… - Lipids in health and …, 2015 - Springer
Background Dyslipidemia is one of the most important independent modifiable risk factors
for cardiovascular diseases. The objective of this study was to determine the prevalence and …
for cardiovascular diseases. The objective of this study was to determine the prevalence and …